On Schrödinger’s Cat and Evaluation of Trials Disrupted by the Covid19 Pandemic: A Critical Appraisal

M. Cesari; Riccardo Calvani; M. Canevelli; I. Aprahamian; Barreto P. de Souto; D. Azzolino; R. A. Fielding; N. Vanacore; M. Inzitari; Emanuele Marzetti

doi:10.14283/jfa.2021.23

On Schrödinger’s Cat and Evaluation of Trials Disrupted by the Covid19 Pandemic: A Critical Appraisal

M. Cesari^*, Riccardo Calvani, M. Canevelli, I. Aprahamian, Barreto P. de Souto, D. Azzolino, R. A. Fielding, N. Vanacore, M. Inzitari, Emanuele Marzetti

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Editoriale

Abstract

From the beginning of 2020, the world has been fighting the SARS-Cov-2 outbreak. The life of each one of us has profoundly hanged. Unavoidably, our clinical routine has drastically modified in its priorities and methodologies (1). The COVID-19 pandemic has also raised\r\nsignificant issues in the field of research. The investigators’ responsibility has increased with the need to thoughtfully weigh the risk-benefit ratio for each protocol in an emergency and evolving scenario (2).

Lingua originale	Inglese
pagine (da-a)	310-312
Numero di pagine	3
Rivista	The Journal of frailty & aging
Volume	10
Numero di pubblicazione	4
DOI	https://doi.org/10.14283/jfa.2021.23
Stato di pubblicazione	Pubblicato - 2021

All Science Journal Classification (ASJC) codes

Invecchiamento
Geriatria e Gerontologia
Fisiologia (medica)

Keywords

COVID-19
Humans
Pandemics
Research
SARS-CoV-2
medicine
methodology
publishing
science

Accesso al documento

10.14283/jfa.2021.23

Altri file e collegamenti

Cita questo

@article{3cee22d484654365ab654ffb0afab127,

title = "On Schr{\"o}dinger{\textquoteright}s Cat and Evaluation of Trials Disrupted by the Covid19 Pandemic: A Critical Appraisal",

abstract = "From the beginning of 2020, the world has been fighting the SARS-Cov-2 outbreak. The life of each one of us has profoundly hanged. Unavoidably, our clinical routine has drastically modified in its priorities and methodologies (1). The COVID-19 pandemic has also raised\textbackslash{}r\textbackslash{}nsignificant issues in the field of research. The investigators{\textquoteright} responsibility has increased with the need to thoughtfully weigh the risk-benefit ratio for each protocol in an emergency and evolving scenario (2).",

keywords = "COVID-19, Humans, Pandemics, Research, SARS-CoV-2, medicine, methodology, publishing, science, COVID-19, Humans, Pandemics, Research, SARS-CoV-2, medicine, methodology, publishing, science",

author = "M. Cesari and Riccardo Calvani and M. Canevelli and I. Aprahamian and \{de Souto\}, \{Barreto P.\} and D. Azzolino and Fielding, \{R. A.\} and N. Vanacore and M. Inzitari and Emanuele Marzetti",

year = "2021",

doi = "10.14283/jfa.2021.23",

language = "English",

volume = "10",

pages = "310--312",

journal = "The Journal of frailty \& aging",

issn = "2260-1341",

publisher = "Serdi Publishing Company",

number = "4",

}

TY - JOUR

T1 - On Schrödinger’s Cat and Evaluation of Trials Disrupted by the Covid19 Pandemic: A Critical Appraisal

AU - Cesari, M.

AU - Calvani, Riccardo

AU - Canevelli, M.

AU - Aprahamian, I.

AU - de Souto, Barreto P.

AU - Azzolino, D.

AU - Fielding, R. A.

AU - Vanacore, N.

AU - Inzitari, M.

AU - Marzetti, Emanuele

PY - 2021

Y1 - 2021

N2 - From the beginning of 2020, the world has been fighting the SARS-Cov-2 outbreak. The life of each one of us has profoundly hanged. Unavoidably, our clinical routine has drastically modified in its priorities and methodologies (1). The COVID-19 pandemic has also raised\r\nsignificant issues in the field of research. The investigators’ responsibility has increased with the need to thoughtfully weigh the risk-benefit ratio for each protocol in an emergency and evolving scenario (2).

AB - From the beginning of 2020, the world has been fighting the SARS-Cov-2 outbreak. The life of each one of us has profoundly hanged. Unavoidably, our clinical routine has drastically modified in its priorities and methodologies (1). The COVID-19 pandemic has also raised\r\nsignificant issues in the field of research. The investigators’ responsibility has increased with the need to thoughtfully weigh the risk-benefit ratio for each protocol in an emergency and evolving scenario (2).

KW - COVID-19

KW - Humans

KW - Pandemics

KW - Research

KW - SARS-CoV-2

KW - medicine

KW - methodology

KW - publishing

KW - science

KW - COVID-19

KW - Humans

KW - Pandemics

KW - Research

KW - SARS-CoV-2

KW - medicine

KW - methodology

KW - publishing

KW - science

UR - https://publicatt.unicatt.it/handle/10807/200985

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85116817828&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85116817828&origin=inward

U2 - 10.14283/jfa.2021.23

DO - 10.14283/jfa.2021.23

M3 - Editorial

SN - 2260-1341

VL - 10

SP - 310

EP - 312

JO - The Journal of frailty & aging

JF - The Journal of frailty & aging

IS - 4

ER -

On Schrödinger’s Cat and Evaluation of Trials Disrupted by the Covid19 Pandemic: A Critical Appraisal

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo